indalotherapuetics.png
 

Indalo Therapeutics

Argonautic iSelect Special Situations Fund I SP (AISS)

Indalo Therapeutics develops novel treatments for fibrotic diseases. Their biotechnology platform offers cutting-edge insights into the molecular drivers of aberrant scarring, enabling fibrotic patients to improve their lives with therapies that arrest or reverse their fibrosis.

VISIT WEBSITE